Ftse Mib
36.200,72
0,24%
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
NASDAQ
19.954,30
-0,50%
Bitcoin
104.527,57
-0,19%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Marker Therapeutics Inc (MRKR) Marker Therapeutics Inc (MRKR) Notizie

Marker Therapeutics Inc

MRKR
2,11
-0,21 (-9,05%)
25 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/1/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
17/1/202522:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/1/202522:05EDGAR2Form PRE 14A - Other preliminary proxy statements
10/1/202523:09EDGAR2Form S-3 - Registration statement under Securities Act of..
26/12/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202422:30EDGAR2Form 8-K - Current report
23/12/202422:30EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
19/12/202414:21EDGAR2Form 8-K - Current report
19/12/202414:06GLOBEMarker Therapeutics Announces $16.1 Million Private..
19/12/202414:05GLOBEMarker Therapeutics Provides a Clinical Update on MT-601 in..
17/12/202413:10EDGAR2Form 8-K - Current report
17/12/202413:00GLOBEMarker Therapeutics Awarded $9.5 Million Grant from the..
10/12/202414:30GLOBEMarker Therapeutics to Present at the 2024 Ladenburg..
06/12/202422:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/11/202422:27EDGAR2Form S-3 - Registration statement under Securities Act of..
26/11/202417:00GLOBEMarker Therapeutics to Present at the Citizens JMP..
14/11/202422:45EDGAR2Form 8-K - Current report
14/11/202422:30GLOBEMarker Therapeutics Reports Third Quarter 2024 Financial..
14/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/8/202414:00GLOBEKorro Announces Addition of Industry Veteran Katharine..
14/8/202422:47EDGAR2Form 8-K - Current report
14/8/202422:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202422:30GLOBEMarker Therapeutics Reports Second Quarter 2024 Financial..
12/8/202413:12EDGAR2Form 8-K - Current report
12/8/202413:00GLOBEMarker Therapeutics Awarded $2 Million Grant from NIH in..
12/6/202422:05EDGAR2Form 8-K - Current report
18/5/202400:25EDGAR2Form SC 13D/A - General statement of acquisition of..
15/5/202422:40EDGAR2Form 8-K - Current report
15/5/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/4/202413:00GLOBEPrincipal Investigator from City of Hope National Medical..
25/3/202422:45GLOBEMarker Therapeutics Reports Year-End 2023 Corporate and..
22/3/202417:30GLOBEMarker Therapeutics to Present at the H.C. Wainwright 2nd..
01/3/202414:02EDGAR2Form 8-K - Current report
26/2/202413:58EDGAR2Form 8-K - Current report
Apertura: 2,36 Min: 2,05 Max: 2,36
Chiusura: 2,32

La tua Cronologia

NASDAQ
MRKR
Marker Therapeutics
BIT
A29552
Aldburg Public
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network